Literature DB >> 6103438

Prediction of relapse in hyperthyroid Graves' disease.

A M McGregor, B R Smith, R Hall, M M Petersen, M Miller, P J Dewar.   

Abstract

Within a year of stopping a 6-month course of carbimazole treatment 41 of 65 patients (63%) with hyperthyroid Graves' disease had a recurrence of their hyperthyroidism. By combined analysis of the HLA-DRw3 status and the level of thyrotrophin-receptor antibody at the time of drug withdrawal relapse or remission could be predicted in 62 of the 65 patients.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6103438     DOI： 10.1016/s0140-6736(80)91551-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  25 in total

1.  Immunogenetic markers in patients with Graves' disease.

Authors:  E Schifferdecker; P Kühnl; K Schöffling; B Manfras; G Holzberger; W Spielmann; B O Böhm
Journal:  Klin Wochenschr       Date:  1991-04-04

Review 2.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

3.  Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.

Authors:  J N Talbot; F Duron; R Féron; P Aubert; G Milhaud
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

4.  Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors:  J Ginsberg; C von Westarp
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

5.  Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?

Authors:  R Wilson; C G Semple; A M Reid; A C Glen; J H McKillop; J A Thomson
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

6.  [Determination of TSH receptor antibodies--clinical value].

Authors:  E Schifferdecker; F Schulz; K Schöffling
Journal:  Klin Wochenschr       Date:  1986-01-02

7.  Differential immunosuppressive action of carbimazole and propylthiouracil.

Authors:  R Wilson; J H McKillop; C Pearson; A K Burnett; J A Thomson
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Thyroidectomy for Graves' disease: is hypothyroidism inevitable?

Authors:  M Davenport; C H Talbot
Journal:  Ann R Coll Surg Engl       Date:  1989-03       Impact factor: 1.891

9.  Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.

Authors:  R Hörmann; B Saller; R Müller; K Mann
Journal:  Klin Wochenschr       Date:  1985-12-16

10.  10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).

Authors:  J Hensen; P Kotulla; R Finke; K Badenhoop; K Koppenhagen; H Meinhold; H Schleusener
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.